U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. CPG Sec 510.100 Beverage Bases
  1. Search for FDA Guidance Documents

COMPLIANCE POLICY GUIDE (CPG)

CPG Sec 510.100 Beverage Bases November 1988

Final
Issued by:
Guidance Issuing Office
Office of Regulatory Affairs
Center for Food Safety and Applied Nutrition

BACKGROUND:

In an issuance identified as TC-215, dated March 21, 1940, we stated:

There would appear to be no objection to designation as a beverage base of a preparation to be mixed with sugar and water to make a beverage, provided the name is accompanied by a conspicuous statement to the effect that the article is to be used with sugar. As you know, there are on the market complete beverage bases, that is, articles to which it is necessary to add only water to make a finished beverage. The purchaser should be able to readily distinguish, by means of the name or accompanying statement, between such articles and those to which sugar must be added by the purchaser before beverages can be made from them.

POLICY:

We consider the designation "beverage base" acceptable as the common or usual name required by section 403(i)(1) of the Federal Food, Drug, and Cosmetic Act and to specify the identity of an article as required by section 4(a)(1) of the Fair Packaging and Labeling Act, provided: the article is one to which only water need be added to make a finished beverage. If ingredients other than water must be added to make the beverage, the name is accompanied by a conspicuous statement concerning the ingredient or ingredients which must be added.

Issued: 12/3/73
Reissued: 10/1/80
Revised: 11/1/88


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.

 
Back to Top